<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Ra Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Ra Pharmaceuticals, Inc.

    Ra PharmaÂŽ is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas Treco, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Enflux, Inc.

    Enflux, Inc.

    We make getting back relief more convenient, inexpensive, and more fun. BackAlert ...

    We make getting back relief more convenient, in...

    Amount Raised:    $11,741.00
    Fundraising Status:    EC
    Filing Type:    CF
    Twist Bioscience Corporation

    Twist Bioscience Corporation

    We are a leading, rapidly growing synthetic biology company that has developed a d...

    We are a leading, rapidly growing synthetic bio...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company th...

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a ...

    Filing Type:    PU
    CASI Pharmaceuticals, Inc.

    CASI Pharmaceuticals, Inc.

    CASI is a U.S. NASDAQ-listed biopharmaceutical company focused on developing and a...

    CASI is a U.S. NASDAQ-listed biopharmaceutical ...

    Filing Type:    PU
    Venomyx, Inc

    Venomyx, Inc

    We're developing Vipax, the world's first portable, shelf-stable, broad-spectrum a...

    We're developing Vipax, the world's first porta...

    Amount Raised:    $290,122.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.